Record stringlengths 1 197k |
|---|
Participation requires completing surveys by email, text message, in person, and/or by telephone. Medical tests will also be done to track the health of participants. conditions: Acetabular Labrum Tear studyType: INTERVENTIONAL phases: NA allocation: NA interventionModel: SINGLE_GROUP primaryPurpose: TREATMENT masking:... |
<|newrecord|> nctId: NCT06332339 id: HVTN 313 briefTitle: Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of 16055 NFL Delta Gly4 Env Protein Trimer and Trimer 4571 Combined With 3M-052-AF + Alum Adjuvant and Ad4-Env145NFL Viral Particles as Heterologous Prime-boost Regimens in Adult Participant... |
The main question\[s\] it aims to answer are: |
* Are these vaccine regimens safe and well tolerated? |
* Are the prime-boost vaccine regimens that include Ad4-Env145NFL and Trimer 4571 as heterologous boosts going contribute to the development of B-cell and antibody responses? |
Participants will attend scheduled study visits to receive their vaccine and will record symptoms on a daily eDiary. conditions: HIV studyType: INTERVENTIONAL phases: PHASE1 allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: PREVENTION masking: NONE count: 50 type: ESTIMATED name: 16055 NFL delta Gly4 t... |
<|newrecord|> nctId: NCT06332326 id: E-10840098-772.02-4966 briefTitle: Investigation of the Efficacy of Non-Invasive Vagus Nerve Stimulation and Physiotherapy in Unilateral Vestibular Hypofunction Patients overallStatus: RECRUITING date: 2022-10-23 date: 2024-04 date: 2024-05 date: 2024-03-27 date: 2024-03-27 name: Me... |
<|newrecord|> nctId: NCT06332313 id: 2023/10/05 briefTitle: Erector Spina Plane Block Volume Comparison overallStatus: NOT_YET_RECRUITING date: 2024-06-12 date: 2024-11-20 date: 2024-12-05 date: 2024-03-27 date: 2024-03-27 name: Kahramanmaras Sutcu Imam University class: OTHER briefSummary: After obtaining ethical comm... |
Patients will be randomized into three groups: Group K, who will receive analgesia with patient-controlled analgesia (PCA) with tramadol only; Group E20, who will receive PCA with 20cc volume of ESP block; and Group E30, who will receive PCA with 30cc volume of ESP block. After standard general anesthesia induction and... |
<|newrecord|> nctId: NCT06332300 id: ADBL-LC-003 briefTitle: An Exploratory Clinical Study of Adebelimumab in Combination With Famitinib and Chemotherapy in Patients With NSCLC overallStatus: RECRUITING date: 2024-02-01 date: 2025-02-01 date: 2026-02-01 date: 2024-03-27 date: 2024-03-27 name: Jiangsu Province Nanjing B... |
<|newrecord|> nctId: NCT06332287 id: 2023-NSCLC briefTitle: A Study of Trilaciclib Combined With Chemotherapy in the Treatment of Advanced NSCLC With Leptomeningeal Metastasis overallStatus: RECRUITING date: 2023-05-01 date: 2024-11-01 date: 2025-06-01 date: 2024-03-27 date: 2024-03-27 name: Jiangsu Province Nanjing Br... |
<|newrecord|> nctId: NCT06332274 id: 2023-503316-33-00 id: 2023/3720 type: OTHER domain: CSET number briefTitle: tislelizUMaB in canceR Patients With molEcuLar residuaL Disease acronym: UMBRELLA overallStatus: NOT_YET_RECRUITING date: 2024-05 date: 2028-05 date: 2029-04 date: 2024-03-27 date: 2024-03-27 name: Gustave R... |
UMBRELLA is a biology-driven trial designed to study the impact of systemic treatment with tislelizumab monotherapy after detection of MRD+ status after completion of surgery and perioperative treatments in patients with cancer of a solid tumor. Residual disease (MRD) will be determined by optimized detection and preci... |
<|newrecord|> nctId: NCT06332261 id: 2024-BB-01 briefTitle: Standardized Assessment in Depression Treatment in Routine Psychiatric Services overallStatus: ACTIVE_NOT_RECRUITING date: 2024-03-08 date: 2024-04 date: 2024-04 date: 2024-03-27 date: 2024-03-27 name: Karolinska Institutet class: OTHER name: Region Stockholm ... |
The main questions it aims to answer are: |
* Are current practices consistent with local clinical guidelines in terms of standardized assessment and the treatments provided? |
* What are the present conditions for implementing measurement-based care in depression treatment in this setting? |
Data will be collected retrospectively from medical records of patients having received psychological or pharmacological treatment for depression from 2020 to 2023. Frequency of standardized assessments (not scores) using the Montgomery-Åsberg Depression Rating Scale, the Montgomery-Åsberg Depression Rating Scale-Self ... |
<|newrecord|> nctId: NCT06332248 id: 2014/1023-31/4 & 2014/274-31/5 briefTitle: Possible Effects of the Dietary Supplement Magnesium Compared to Placebo overallStatus: COMPLETED date: 2014-09-15 date: 2015-05-20 date: 2015-05-28 date: 2024-03-27 date: 2024-03-27 name: Dan Hasson class: OTHER name: Stiftelsen Stressmott... |
* Are there differences in ratings of health, stress, well-being and work environment indicators between individuals intaking 375 mg magnesium (daily for 3 months) compared to placebo? |
* Are there differences in hearing, measured with hearing tests between those receiving 375 mg magnesium compared to placebo? |
Participants were asked to ingest 375 mg magnesium or placebo daily for 3 months. |
Researchers compared the group ingesting magnesium with the group ingesting placebo pills to see if there were any differences in for example self-rated health, recovery, wellbeing, etc. conditions: Health Promotion studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL interventionMode... |
<|newrecord|> nctId: NCT06332235 id: KMUHIRB-F(I)-20220023 briefTitle: Efficacy and Safety of Silodosin in the Treatment of Lower Urinary Tract Symptoms in Taiwanese Population. overallStatus: RECRUITING date: 2022-02-18 date: 2024-09-30 date: 2024-12-31 date: 2024-03-27 date: 2024-03-27 name: Kaohsiung Medical Univers... |
<|newrecord|> nctId: NCT06332222 id: 1987 briefTitle: Recovery With Tart Cherry Supplementation Following a Marathon. overallStatus: COMPLETED date: 2023-04-01 date: 2023-10-11 date: 2023-10-11 date: 2024-03-27 date: 2024-03-27 name: Northumbria University class: OTHER name: Iprona Lana SpA briefSummary: The goal of th... |
The main questions it aimed to answer were whether 7 day supplementation with Vistula TC attenuated: |
* muscle function |
* inflammation |
* soreness following a marathon run. |
Participants will either consume a spray-dried tart cherry supplement or a calorie-matched placebo-control for 7 days, and complete a marathon. Participants will perform functional tests, be assessed for their perceptual recovery and markers of inflammation and muscle damage via: |
* maximal voluntary contractions |
* counter movement jumps |
* visual analog scales to assess soreness |
* blood samples conditions: Exercise Recovery studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: BASIC_SCIENCE masking: TRIPLE whoMasked: PARTICIPANT whoMasked: INVESTIGATOR whoMasked: OUTCOMES_ASSESSOR count: 35 type: ACTUAL name: Tart Cherry name: Placebo measure: ... |
<|newrecord|> nctId: NCT06332209 id: Pro00135303 id: U66RH31458 type: OTHER_GRANT domain: Telehealth Center of Excellence briefTitle: Randomized Trial of Tele Vs. Clinic TF-CBT in Puerto Rico overallStatus: NOT_YET_RECRUITING date: 2024-06-01 date: 2025-09-30 date: 2025-09-30 date: 2024-03-27 date: 2024-03-29 name: Med... |
<|newrecord|> nctId: NCT06332196 id: L-IEI briefTitle: Immunodeficiency and Cancer: Identification of Congenital Immune System Defects Underlying Paediatric Lymphomas overallStatus: RECRUITING date: 2023-10-18 date: 2025-06-18 date: 2025-10-18 date: 2024-03-27 date: 2024-03-27 name: Meyer Children's Hospital IRCCS clas... |
<|newrecord|> nctId: NCT06332183 id: ECDGWAS briefTitle: GWAS and EWAS in Patients With Erdheim-Chester Disease overallStatus: RECRUITING date: 2019-07-17 date: 2024-07-01 date: 2024-10-01 date: 2024-03-27 date: 2024-03-27 name: Augusto Vaglio class: OTHER briefSummary: Erdheim-Chester Disease (ECD) is a rare form of h... |
This study aims to analyze the entire genome of a large cohort of patients with ECD and healthy controls to determine whether there are polymorphisms and epigenetic variants associated with susceptibility to developing the disease. The study could thus clarify the genetic predisposition to ECD development, provide insi... |
<|newrecord|> nctId: NCT06332170 id: HS-20093-103 briefTitle: ARTEMIS-101: A Study of HS-20093 Combinations in Patients With Advanced Solid Tumors overallStatus: NOT_YET_RECRUITING date: 2024-05-30 date: 2026-05-30 date: 2028-05-30 date: 2024-03-27 date: 2024-03-27 name: Hansoh BioMedical R&D Company class: INDUSTRY br... |
<|newrecord|> nctId: NCT06332157 id: 2023-ke-715-1 briefTitle: Postoperative Quality of Recovery After General Anesthesia With Remimazolam overallStatus: NOT_YET_RECRUITING date: 2024-06 date: 2025-12 date: 2025-12 date: 2024-03-27 date: 2024-03-27 name: Beijing Chao Yang Hospital class: OTHER briefSummary: 126 patient... |
<|newrecord|> nctId: NCT06332144 id: 1R56DC020208-01A1 type: NIH link: https://reporter.nih.gov/quickSearch/1R56DC020208-01A1 briefTitle: Predicting Language and Literacy Growth in Children With ASD Using Statistical Learning acronym: PLAUSL overallStatus: RECRUITING date: 2024-01-13 date: 2024-08-31 date: 2024-08-31 d... |
1. whether children's statistical learning abilities can predict their long-term improvement of language and literacy skills in school; |
2. how children's brains automatically learn patterns from speech and prints; |
3. whether children's learning in the lab reflects the language patterns they have learned over the years from their native language. |
First-grade students will participate in the study twice across three months. |
During Time 1, children will complete |
* a battery of language, reading, and cognitive assessments |
* a series of computer-based statistical learning games both inside and outside of functional MRI scanner. |
During Time 2, children will complete a battery of language and reading assessments to detect the growth in three months. |
Researchers will compare the autistic and the non-autistic groups to see if statistical learning plays a similar or different role in predicting children's language and literacy growth. conditions: Autism Spectrum Disorder conditions: Language Development conditions: Literacy studyType: OBSERVATIONAL observationalModel... |
<|newrecord|> nctId: NCT06332131 id: UPCC07623 briefTitle: Effects of Immune Checkpoint Inhibitors on Coronary Microvasculature overallStatus: NOT_YET_RECRUITING date: 2024-04 date: 2027-04 date: 2027-04 date: 2024-03-27 date: 2024-04-10 name: Abramson Cancer Center at Penn Medicine class: OTHER briefSummary: This is a... |
<|newrecord|> nctId: NCT06332118 id: avf ice massage briefTitle: The Effect of Ice Massage on Pain, Ecchymosis, Hematoma and Patient Satisfaction overallStatus: NOT_YET_RECRUITING date: 2024-04-15 date: 2024-05-15 date: 2024-05-30 date: 2024-03-27 date: 2024-04-02 name: Erzurum Technical University class: OTHER briefSu... |
<|newrecord|> nctId: NCT06332105 id: CUK001 briefTitle: Evaluation of Low Phenylalanine Formulas overallStatus: ACTIVE_NOT_RECRUITING date: 2023-01-30 date: 2025-01 date: 2025-04 date: 2024-03-27 date: 2024-04-15 name: Ajinomoto Co., Inc. class: INDUSTRY name: Birmingham Children's Hospital name: Great Ormond Street Ho... |
<|newrecord|> nctId: NCT06332092 id: FID-007-003 briefTitle: FID-007 and Cetuximab in Treating Patients With Advanced Head and Neck Squamous Cell Carcinoma acronym: HNSCC overallStatus: RECRUITING date: 2024-04-10 date: 2025-03-31 date: 2025-12-31 date: 2024-03-27 date: 2024-04-17 name: Fulgent Pharma LLC. class: INDUS... |
<|newrecord|> nctId: NCT06332079 id: HAITI 2023-505356-22-00 briefTitle: Holmium-166 TARE in Liver Limited Unresectable Colorectal Cancer Patients acronym: HAITI overallStatus: RECRUITING date: 2024-03-13 date: 2026-11 date: 2027-02 date: 2024-03-27 date: 2024-03-27 name: Gruppo Oncologico del Nord-Ovest class: OTHER b... |
A total of 23 patients will be enrolled in each cohort. primaryPurpose: TREATMENT masking: NONE count: 46 type: ESTIMATED name: 166Holmium TARE name: Cetuximab name: Panitumumab name: 5-Fluorouracil name: Bevacizumab name: Capecitabine measure: Progression-free survival (PFS) Rate measure: Overall Toxicity rate measure... |
<|newrecord|> nctId: NCT06332066 id: 0046-24-COM briefTitle: Oxytocin Administration to Therapists and Its Effects on Patient-perceived Attunement and Responsiveness overallStatus: NOT_YET_RECRUITING date: 2024-05-01 date: 2024-05-30 date: 2024-06-30 date: 2024-03-27 date: 2024-03-27 name: Shalvata Mental Health Center... |
<|newrecord|> nctId: NCT06332053 id: SY-5007-I-03 briefTitle: A Study to Evaluate the Effect of Itraconazole and Rifampicin on the Pharmacokinetics of SY-5007 in Healthy Subjects overallStatus: NOT_YET_RECRUITING date: 2024-04-01 date: 2024-06-01 date: 2024-06-01 date: 2024-03-27 date: 2024-03-27 name: Shouyao Holdings... |
<|newrecord|> nctId: NCT06332040 id: 22-500-243-50-35 briefTitle: Gentamicin Bladder Instillation on CAUTI overallStatus: RECRUITING date: 2023-10-09 date: 2026-10-08 date: 2026-10-08 date: 2024-03-26 date: 2024-03-26 name: St. Joseph's Hospital and Medical Center, Phoenix class: OTHER briefSummary: Urinary tract infec... |
<|newrecord|> nctId: NCT06332027 id: Soh-Med-24-03-03MD briefTitle: Accuracy of Hystro-Salpingo-Foam-Sonography (HYFOSY) as Tubal Patency Test in Comparison to Laparoscopy in Infertile Patients overallStatus: NOT_YET_RECRUITING date: 2024-04-01 date: 2025-04-01 date: 2025-04-01 date: 2024-03-26 date: 2024-03-26 name: S... |
Laparoscopy is an invasive test, with a risk of intra-abdominal bleeding, visceral damage, and risks related to general anaesthesia. |
Traditionally, Hysterosalpingography(HSG) is a less invasive less expensive first-step alternative, which has been used for decades with disadvantages such as radiation exposure, discomfort, or even abdominal pain. |
Hysterosalpingo-Contrast Sonography (HyCoSy) was introduced as an alternative using either contrast media or saline. The accuracy of HyCoSy is comparable to that of HSG and LSC being reference standards for tubal patency testing.However, hyperechogenic contrast media such as Echovist_ (Schering AG, Berlin) and SonoVue_... |
Hysterosalpingo-Foam Sonography (HyFoSy) was developed as an alternative for contrast HyCoSy and was introduced in 2010 as a first-line office tubal patency test.Foam is used in the HyFoSy technique to visualize the fallopian tubes and is created by rigorously mixing 5mlExEm_-gel (containing hydroxyethyl cellulose and ... |
The ExEm_-foam is sufficiently fluid to pass the fallopian tubes and in the mean time sufficiently stable to show echogenicity for at least five minutes, which is an advantage over saline. In a review on safety aspects and side effects of ExEm-gel it was considered to be appropriate and safe for tubal patency testing. |
In 2017, HyLiFoSy combined with power Doppler (PD)(HyLiFoSy-PD) technique was described as a possibly less painful and easier to detect on ultrasound alternativeto HyFoSy and HyCoSy, which can be used whenever the contrast media used with both are either unavailable or is relatively expensive Ultrasound-based tubal pat... |
In addition, they allow for a single comprehensive assessment of the uterus and the fallopian tubes and it can be performed by the same specialist who indicates it, in the clinician's own office with it consequently being time efficient. Finally, some studies have shown an increase in the rate of post-procedure gestati... |
<|newrecord|> nctId: NCT06332014 id: 20210123 briefTitle: Evaluation of Efficacy and Safety of Prolia in Subjects of Male Osteoporosis in Mainland China overallStatus: NOT_YET_RECRUITING date: 2024-07-31 date: 2026-07-29 date: 2026-07-29 date: 2024-03-26 date: 2024-03-26 name: Amgen class: INDUSTRY briefSummary: The pr... |
<|newrecord|> nctId: NCT06332001 id: IEO 1403 briefTitle: Evaluation of a Music and Interaction Intervention on Patient Distress During Whole Body Magnetic Resonance overallStatus: RECRUITING date: 2020-12-31 date: 2024-12-31 date: 2024-12-31 date: 2024-03-26 date: 2024-03-26 name: European Institute of Oncology class:... |
Subjects will be randomized into two groups: the experimental group or arm that receives the music and interaction interventions, and the control group or arm that receives a standard care condition. conditions: Neoplasm Malignant studyType: OBSERVATIONAL observationalModel: COHORT timePerspective: PROSPECTIVE count: 2... |
<|newrecord|> nctId: NCT06331988 id: IEO 1341 briefTitle: Microbiome, Immune-system and Tumor Interaction in Colorectal Cancer acronym: MITICO overallStatus: RECRUITING date: 2022-07-21 date: 2026-07-31 date: 2029-07-31 date: 2024-03-26 date: 2024-03-27 name: European Institute of Oncology class: OTHER briefSummary: Co... |
Adjuvant systemic chemotherapy can reduce the risk of disease recurrence in patients with colorectal adenocarcinomas, however, the standard drugs used to date for this use (fluoropyrimidines and oxaliplatin) have not undergone substantial changes in the last 20 years or so. |
A crucial point is the need to have more precise information regarding risk factors above all biomolecular to base therapeutic choices. |
It has now become urgent to overcome the T-tumor N-node M- metastasis (TNM) staging, to have more modern knowledge on the factors capable of impacting significantly on the prognosis, influence the real risk of disease recurrence, Identify new prognostic categories and subcategories, therefore being able to predict the ... |
<|newrecord|> nctId: NCT06331975 id: IEO 0836 briefTitle: Radiomics and Radiogenomics of Non-small Cell Lung Cancer overallStatus: COMPLETED date: 2018-06-12 date: 2023-01-31 date: 2023-09-14 date: 2024-03-26 date: 2024-03-26 name: European Institute of Oncology class: OTHER briefSummary: In this study, the radiomic ch... |
<|newrecord|> nctId: NCT06331962 id: B-ER-112-010 briefTitle: Digestive Tract Cancer and CIPN overallStatus: RECRUITING date: 2023-05-19 date: 2025-07-31 date: 2025-07-31 date: 2024-03-26 date: 2024-03-26 name: National Cheng-Kung University Hospital class: OTHER name: National Cheng Kung University briefSummary: Accor... |
<|newrecord|> nctId: NCT06331949 id: TR TOKAT02 briefTitle: Video Supported Training on Non-Stress Test Application to Pregnant Women overallStatus: NOT_YET_RECRUITING date: 2024-04-01 date: 2024-11-01 date: 2024-11-01 date: 2024-03-26 date: 2024-03-26 name: Hilal Özbek class: OTHER briefSummary: Women go through many ... |
<|newrecord|> nctId: NCT06331936 id: Shenzhen Project briefTitle: Improving Emotional Regulation Skills of Children in Difficulty in Shenzhen overallStatus: RECRUITING date: 2024-01-06 date: 2024-06 date: 2024-09 date: 2024-03-26 date: 2024-03-26 name: City University of Hong Kong class: OTHER name: International Socia... |
<|newrecord|> nctId: NCT06331923 id: U1111-1305-0484 briefTitle: Assessing the Effectiveness of Continuous Glucose Monitoring in Enhancing Surgical Outcomes for Diabetic Patients overallStatus: RECRUITING date: 2024-04-12 date: 2025-10-31 date: 2025-12-31 date: 2024-03-26 date: 2024-04-16 name: Beijing Tsinghua Chang G... |
* To assess the effectiveness of CGM compared with conventional monitoring in reducing the comprehensive complication index (CCI) for patients with diabetes or impaired glucose tolerance (IGT) within 30 days after surgery. |
* To analyze the impact of different age groups, types of surgery, preoperative levels of HbA1c, and preoperative 24h glycemic variations on the improvement of surgical outcomes under the CGM model. |
Participants will receive CGM prescribed by the attending physician for at least 6 hours before surgery. Glucose monitoring should be continued until the 7th day after surgery or discharge. |
The investigators will compare conventional monitoring group to see if CGM could reduce the CCIs for patients with diabetes or impaired glucose tolerance within 30 days after surgery. conditions: Comprehensive Complication Index studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL pri... |
<|newrecord|> nctId: NCT06331910 id: TITNCUES briefTitle: Efficacy and Safety of Topical Insulin for Neurotrophic Corneal Ulcers overallStatus: NOT_YET_RECRUITING date: 2024-04-01 date: 2025-04-01 date: 2025-05-01 date: 2024-03-26 date: 2024-03-26 name: Assiut University class: OTHER briefSummary: To evaluate Safety an... |
<|newrecord|> nctId: NCT06331897 id: Bronchial asthma briefTitle: Bronchial Asthma & Its Exacerbation overallStatus: NOT_YET_RECRUITING date: 2025-01-01 date: 2026-01-01 date: 2026-06-01 date: 2024-03-26 date: 2024-03-26 name: Assiut University class: OTHER briefSummary: Our goals is to assess : |
1¬_ the role of spirometer in case of asthma exacerbation 2_hematological parameters (N/L ratio \& platelet indices \&CRP )in asthma exacerbation for diagnosing and classifying asthma severity and its exacerbation conditions: Bronchial Asthma studyType: OBSERVATIONAL observationalModel: OTHER timePerspective: P... |
<|newrecord|> nctId: NCT06331884 id: PCZ_Phase1 briefTitle: Phase 1 Study to Evaluate Safety, Tolerability and Pharmacokinetics/-Dynamics of AK1967 (Procizumab) overallStatus: RECRUITING date: 2024-03-07 date: 2024-07-31 date: 2024-07-31 date: 2024-03-26 date: 2024-03-26 name: 4TEEN4 Pharmaceuticals GmbH class: INDUSTR... |
Recently, a cDPP3-antagonizing antibody called AK1967 (commonly referred to as Procizumab) has been developed. In animal models of cardiogenic- and septic shock, inhibition of cDPP3 by AK1967 resulted in improved cardiac function and survival. Furthermore, AK1967 has shown an excellent safety record in different precli... |
<|newrecord|> nctId: NCT06331871 id: 2004202111621 briefTitle: Effectiveness of US-PENS for Patients With Post-surgical Shoulder Pain overallStatus: RECRUITING date: 2024-02-01 date: 2025-10-30 date: 2025-10-30 date: 2024-03-26 date: 2024-03-26 name: Universidad Rey Juan Carlos class: OTHER briefSummary: The aim of thi... |
This is a randomized, longitudinal, prospective and quasi-experimental clinical trial in which a total of 70 patients divided into two groups; physiotherapy protocol group (n=35) and experimental group to which the same protocol was practiced and a US-PENS session was added (n=35). |
The intervention and follow-up period of the participants took place over 12 weeks. conditions: Ultrasound-Guided Percutaneous Electrical Nerve Stimulation studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL interventionModelDescription: 70 patients with shoulder pain undergoing arth... |
<|newrecord|> nctId: NCT06331858 id: KutahyaHSU-DRGOKPINARDROMER-43 briefTitle: The Effect of Adding Instrumented Hip Concentric Abductor Strengthening Exercise in Knee Osteoarthritis overallStatus: RECRUITING date: 2023-09-20 date: 2024-03-29 date: 2024-03-29 date: 2024-03-26 date: 2024-03-26 name: Kutahya Health Scie... |
2. CONTROL GROUP primaryPurpose: TREATMENT masking: DOUBLE maskingDescription: Before and after the treatment, all patients were evaluated by a blind evaluator in terms of physical examination, pain and functionality, physical performance, quality of life and gait parameters. whoMasked: INVESTIGATOR whoMasked: OUTCOMES... |
<|newrecord|> nctId: NCT06331845 id: NPC012 briefTitle: Stop and go Strategy as First-line Treatment for Widely Metastatic Nasopharyngeal Carcinoma overallStatus: NOT_YET_RECRUITING date: 2024-05-01 date: 2026-05-01 date: 2028-05-01 date: 2024-03-26 date: 2024-03-26 name: Fujian Cancer Hospital class: OTHER_GOV briefSu... |
<|newrecord|> nctId: NCT06331832 id: 2323-EAP id: 2021-002339-44 type: EUDRACT_NUMBER briefTitle: Expanded Access of Imvotamab (IGM-2323) in Patients With R/R NHL overallStatus: NO_LONGER_AVAILABLE date: 2024-03-26 date: 2024-03-26 name: IGM Biosciences, Inc. class: INDUSTRY briefSummary: Expanded Access of Imvotamab (... |
<|newrecord|> nctId: NCT06331819 id: 7-3-2024 briefTitle: Clinical Association Between Obstructive Sleep Apnea, Facial Pigmentation, and Vasovagal Symptoms. acronym: VasOSA overallStatus: RECRUITING date: 2024-03-10 date: 2025-01-01 date: 2025-03-01 date: 2024-03-26 date: 2024-03-26 name: Jordan Collaborating Cardiolog... |
* To prospectively obtain demographic and clinical information of patients referred for a sleep study. |
* To determine the diagnostic value of facial discoloration as potential marker for obstructive sleep apnea to increase detection rate for the condition. |
* To establish a correlation between obstructive sleep apnea and vasovagal symptoms with resulting increased smoking tendency and study the effect of treatment on the disorders. |
* To determine the association between timing of appearance of obstructive sleep apnea symptoms and initiation of smoking. conditions: Obstructive Sleep Apnea conditions: Vasovagal Syncope conditions: Smoking conditions: Acanthosis Nigricans studyType: OBSERVATIONAL observationalModel: COHORT timePerspective: PROSPECTI... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.